Suppr超能文献

原发性肝细胞癌的种族差异:初诊时的肿瘤分期、手术治疗及生存情况。

Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.

作者信息

Sloane Dana, Chen Hegang, Howell Charles

机构信息

University of Maryland School of Medicine, Baltimore MD, USA.

出版信息

J Natl Med Assoc. 2006 Dec;98(12):1934-9.

Abstract

OBJECTIVES

The incidence and mortality rates from primary hepatocellular carcinoma (HCC) are higher in black Americans compared to whites. The goal of this study was to determine if there are racial disparities in HCC stage at diagnosis and treatment.

METHODS

We compared patient age, tumor stage, rates of surgical intervention and survival in black (n=1718) and white (n=9752) HCC cases between 1992 and 2001 in the Surveillance, Epidemiology and End Results (SEER)-11 + Alaska database.

RESULTS

Black HCC cases were significantly younger at diagnosis (p < 0.0001). Black cases were more likely to have regional and distant metastasis at presentation (p < 0.0005) and were less likely to have surgery performed (p < 0.001). The racial difference in surgery treatment was significant among patients with localized (p = 0.001) and regional (p = 0.012) HCC, but not with distant HCC. Overall survival rates were lower in blacks (p = 0.0033). Survival was similar in blacks and whites with regional and distant disease. Yet, among patients with localized HCC, survival rates were lower in blacks (p = 0.0030).

CONCLUSIONS

Black HCC patients have more advanced tumor stage at diagnosis and lower rates of both surgical intervention and survival. The racial disparities in surgical treatment utilization and survival were most striking between black and white HCC patients with localized HCC.

摘要

目的

与白人相比,美国黑人原发性肝细胞癌(HCC)的发病率和死亡率更高。本研究的目的是确定在HCC诊断和治疗阶段是否存在种族差异。

方法

我们在监测、流行病学和最终结果(SEER)-11 +阿拉斯加数据库中比较了1992年至2001年间黑人(n = 1718)和白人(n = 9752)HCC病例的患者年龄、肿瘤分期、手术干预率和生存率。

结果

黑人HCC病例诊断时明显更年轻(p < 0.0001)。黑人病例在就诊时更有可能出现区域和远处转移(p < 0.0005),且进行手术的可能性较小(p < 0.001)。手术治疗的种族差异在局限性(p = 0.001)和区域性(p = 0.012)HCC患者中显著,但在远处HCC患者中不显著。黑人的总体生存率较低(p = 0.0033)。患有区域和远处疾病的黑人和白人的生存率相似。然而,在局限性HCC患者中,黑人的生存率较低(p = 0.0030)。

结论

黑人HCC患者在诊断时肿瘤分期更晚,手术干预率和生存率更低。在局限性HCC的黑人和白人HCC患者之间,手术治疗利用率和生存率的种族差异最为显著。

相似文献

4
Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.
Mayo Clin Proc. 2016 Sep;91(9):1173-82. doi: 10.1016/j.mayocp.2016.06.009. Epub 2016 Aug 3.
5
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):551-559.e1. doi: 10.1016/j.cgh.2018.05.039. Epub 2018 May 31.
6
Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.
J Gastrointest Surg. 2007 Dec;11(12):1636-46; discussion 1646. doi: 10.1007/s11605-007-0315-8. Epub 2007 Oct 3.
7
State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Hepatology. 2021 Sep;74(3):1384-1394. doi: 10.1002/hep.31811. Epub 2021 Jun 11.
8
Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Am J Prev Med. 2018 Nov;55(5 Suppl 1):S40-S48. doi: 10.1016/j.amepre.2018.05.030.
9
Does race affect management and survival in hepatocellular carcinoma in the United States?
Surgery. 2015 Nov;158(5):1244-51. doi: 10.1016/j.surg.2015.03.026. Epub 2015 May 6.
10
Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000.
Clin Gastroenterol Hepatol. 2006 Mar;4(3):355-60. doi: 10.1016/j.cgh.2005.12.022.

引用本文的文献

3
Disparities in Access to Liver Transplant Referral and Evaluation among Patients with Hepatocellular Carcinoma in Georgia.
Cancer Res Commun. 2024 Apr 22;4(4):1111-1119. doi: 10.1158/2767-9764.CRC-23-0541.
5
Incidence, Risk Factors, and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases.
Curr Med Sci. 2024 Feb;44(1):180-186. doi: 10.1007/s11596-023-2809-3. Epub 2024 Feb 23.
7
Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.
JAMA Netw Open. 2023 Dec 1;6(12):e2346380. doi: 10.1001/jamanetworkopen.2023.46380.
8
Health Care Disparities in Transsphenoidal Surgery for Pituitary Tumors: An Experience from Neighboring Urban Public and Private Hospitals.
J Neurol Surg B Skull Base. 2022 Oct 10;84(6):560-566. doi: 10.1055/s-0042-1757613. eCollection 2023 Dec.
9
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single Center.
Fed Pract. 2022 Aug;39(Suppl 3):S64-S67a. doi: 10.12788/fp.0304. Epub 2022 Aug 13.
10
Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
J Gastrointest Cancer. 2023 Jun;54(2):332-356. doi: 10.1007/s12029-022-00851-x. Epub 2022 Jul 26.

本文引用的文献

1
Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000.
Clin Gastroenterol Hepatol. 2006 Mar;4(3):355-60. doi: 10.1016/j.cgh.2005.12.022.
2
The effect of race on invasive staging and surgery in non-small-cell lung cancer.
J Clin Oncol. 2006 Jan 20;24(3):413-8. doi: 10.1200/JCO.2005.02.1758. Epub 2005 Dec 19.
3
Racial differences in oral and pharyngeal cancer treatment and survival in Florida.
Cancer Causes Control. 2004 Aug;15(6):601-9. doi: 10.1023/B:CACO.0000036166.21056.f9.
4
Disparity in use of orthotopic liver transplantation among blacks and whites.
Liver Transpl. 2004 Jul;10(7):834-41. doi: 10.1002/lt.20174.
5
Cancer disparities by race/ethnicity and socioeconomic status.
CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93. doi: 10.3322/canjclin.54.2.78.
6
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.
Ann Intern Med. 2003 Nov 18;139(10):817-23. doi: 10.7326/0003-4819-139-10-200311180-00009.
7
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
Am J Gastroenterol. 2003 Sep;98(9):2060-3. doi: 10.1111/j.1572-0241.2003.t01-1-07641.x.
8
Racial and ethnic disparities in the receipt of cancer treatment.
J Natl Cancer Inst. 2002 Mar 6;94(5):334-57. doi: 10.1093/jnci/94.5.334.
9
Rising incidence of hepatocellular carcinoma in the United States.
N Engl J Med. 1999 Mar 11;340(10):745-50. doi: 10.1056/NEJM199903113401001.
10
Cost considerations as potential barriers to cancer treatment.
Cancer Pract. 1998 May-Jun;6(3):182-7. doi: 10.1046/j.1523-5394.1998.006003182.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验